Clover Corporation's Omega-3 Technology Drives a Fivefold Profit Jump
Fund managers say Clover is successfully diversifying beyond its historical reliance on infant formula sales cycles
31 Mar 2026 · 3 min read
In short
Clover Corporation's FY25 net profit after tax increased to $7.5 million from $1.4 million, on 38% revenue growth.
Shares rose 26.6% in the March 2026 quarter to a more than two-year high, following a strong interim result.
The company is diversifying beyond its historical reliance on infant milk formula sales cycles into broader food and beverage applications.
Nutritional ingredients supplier Clover Corporation delivered a fivefold increase in net profit in FY25, and its share price hit a more than two-year high in early 2026 as its encapsulated omega-3 technology found growing demand beyond infant formula.
A fivefold profit increase on new product launches
NorthStar Impact Funds' September 2025 update reported strong FY25 results: revenue up 38 per cent, with net profit after tax increasing to $7.5 million from $1.4 million the previous year, growth the company attributed to customer product launches across Asia and Europe using its encapsulation technology, which enables nutritional oils like fish and omega-3 to be added as supplements to infant milk formula, foods and beverages.
Reducing historical reliance on infant formula cycles
DMX Asset Management's March 2026 update noted Clover's revenues had historically been closely tied to infant milk formula sales cycles, a source of volatility the company has been working to diversify away from through expansion into broader food and beverage applications for its encapsulated DHA omega-3 ingredients.
A strong interim result lifts shares to a two-year high
Perpetual Asset Management's March 2026 update reported shares rising 26.6 per cent in the March quarter to a more than two-year high, driven by a solid interim result showing strong year-on-year first-half growth. NorthStar Impact Funds confirmed the share price strength was primarily driven by the improving underlying demand profile for Clover's specialty nutritional lipids across its core infant formula manufacturer customer base and adjacent applications.
Clover Corporation (CLV) made a strong positive contribution to performance over the quarter, with the share price rising 26.6% in Q3 FY26 to a more than two year high. The rally was driven by a solid interim result in March, with the company delivering strong year on year 1H FY26 growth.
— Perpetual Asset Management, Monthly Report, March 2026
Questions
How much did Clover Corporation's profit grow in FY25?
NorthStar Impact Funds reported Clover's FY25 net profit after tax increased to $7.5 million from $1.4 million the previous year, on revenue growth of 38%, driven by customer product launches across Asia and Europe.
Why did Clover Corporation shares hit a two-year high in 2026?
Perpetual Asset Management said shares rose 26.6% in the March 2026 quarter to a more than two-year high, driven by a solid interim result showing strong year-on-year first-half growth.
Is Clover Corporation still reliant on infant formula sales cycles?
DMX Asset Management said Clover's revenues have historically been closely tied to infant milk formula sales cycles, though the company is working to diversify into broader food and beverage applications for its encapsulated omega-3 ingredients.
3 managers, 6 comments, with each manager's latest recorded position.
See CLV